CD83 is a regulator of murine B cell function in vivo
✍ Scribed by Minka Breloer; Birte Kretschmer; Katja Lüthje; Svenja Ehrlich; Uwe Ritter; Thomas Bickert; Christiane Steeg; Simon Fillatreau; Kai Hoehlig; Vassiliki Lampropoulou; Bernhard Fleischer
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 512 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Background Differences between human and murine B cells exist at all stages of B‐cell development, including the stage of memory B‐cell formation. B cells in mice are identified with the pan–B‐cell–specific CD45 isoform, B220. In initial studies in humans, it appeared that B220 expr
## Objective: To determine how in vivo modulation of cd44 function by antibodies influences disease severity in a murine model of rheumatoid arthritis. ## Methods: Mice with proteoglycan (pg)-induced arthritis were subjected to systemic treatment with 3 different monoclonal antibodies against cd4
## Abstract Aberrant smooth muscle cell (SMC) plasticity has been implicated in a variety of vascular disorders including atherosclerosis, restenosis, and abdominal aortic aneurysm (AAA) formation. While the pathways governing this process remain unclear, epigenetic regulation by specific microRNAs
## Abstract The murine equivalent to CD2, previously known as a T cell marker, is expressed on mouse B cells. The monoclonal anti‐CD2 antibody 12‐15 was found to induce B cell homotypic adhesion. When treated with F(ab')2 fragments of 12‐15, purified, resting B cells aggregate within 2 h of incubat